AABB conducts assessments every two years of institutional member facilities that procure, process, store and/or distribute cellular therapy products to ensure they meet the association’s voluntary standards. This section includes lists of
hematopoietic progenitor cell, umbilical cord blood stem cell, somatic cell product and clinical services facilities in the U.S. and worldwide that have earned AABB accreditation.
October 23, 2020
September 04, 2020
August 07, 2020